CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS
· Delayed Price · Currency is USD
0.0341
-0.0004 (-1.02%)
At close: Mar 6, 2026
CERO Market Cap
CERO has a market cap or net worth of $1.02 million as of March 6, 2026. Its market cap has decreased by -83.57% in one year.
Market Cap
1.02M
Enterprise Value
8.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 1.02M, a decrease of -99.54%. That is a compound annual growth rate of -71.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.02M | -27.76% |
| Dec 31, 2025 | 1.41M | -87.73% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emmaus Life Sciences | 1.02M |
| Eastgate Biotech | 1.06M |
| Halberd | 1.09M |
| International Stem Cell | 1.13M |
| Evofem Biosciences | 1.14M |
| EV Biologics | 840.53K |
| Vaxxinity | 1.27M |
| Protagenic Therapeutics | 811.84K |